This novel Mass Spectrometry based workflow can simultaneously quantify a comprehensive array of Amyloid beta species including the classical 1-40 and 1-42 biomarkers along with 11 other N- and C-terminal truncated forms using only 200uL of CSF. The Amyloid beta Isoforms Assay has been qualified in 62 CSF samples (31 AD vs. 31 control) with CV's below 10% for most isoforms.
The Amyloid beta Isoforms Assay is a "Fit For Purpose" research tool with applications in early stage clinical trials. Read More.
distributed by |